TARS1 and breast carcinoma: KM plotter data showed that breast cancer groups with high TARS1 had significantly lower overall survival rates (HR=1.71, P=0.001), progress-free interval (HR=1.82, P=0.001), and disease-specific survival (HR=1.86, P=0.006).